Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.088,33
-1,02%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Biogen Inc (BIIB) Biogen Inc (BIIB) Notizie

Biogen Inc

BIIB
208,50
6,04 (2,98%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/4/202401:30PRNUSEisai Completes Submission of LEQEMBI® (lecanemab-irmb)..
06/3/202413:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
04/3/202422:15GLOBEBiogen Highlights New Data at the International Conference..
27/2/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202413:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
22/2/202416:12EDGAR2Form 144 - Report of proposed sale of securities
22/2/202403:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:24EDGAR2Form 144 - Report of proposed sale of securities
21/2/202403:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202413:07EDGAR2Form 8-K - Current report
13/2/202401:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202401:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
12/2/202417:10EDGAR2Form 144 - Report of proposed sale of securities
10/2/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202416:44EDGAR2Form 144 - Report of proposed sale of securities
31/1/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202420:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202313:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202315:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202312:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
Apertura: 201,22 Min: 199,10 Max: 210,83
Chiusura: 202,46

La tua Cronologia

NASDAQ
BIIB
Biogen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network